Can Targeting the Microenvironment Improve Cancer Therapy?
Yes, targeting the TME is an emerging strategy in cancer therapy. For instance, immune checkpoint inhibitors can block proteins that suppress immune responses, thereby enhancing the ability of the immune system to attack cancer cells. Anti-angiogenic therapies aim to disrupt the blood supply to the tumor, starving it of necessary nutrients.
